Hello Interloper!
Menu
Mounjaro® is the latest injectable treatment that has been approved in the UK, which helps the body to both control blood glucose (sugars) after meals and regulate appetite. Clinical trials have shown it’s more effective in controlling blood sugar and lead to greater weight loss compared even with Semaglutide. Tirzepatide is derived from a protein with a similar structure to the hormone GIP (glucose-dependent insulinotropic peptide), but it also binds to the GLP-1 receptors which also has a role in insulin release and appetite control. The dual action unsurprisingly has a more significant impact on appetite control. This makes Tirzepatide the first “dual-hormone agonist” approved for both Type 2 Diabetes as well as weight management. Wegovy and Mounjaro remain at the forefront of medical weight management options.